The World Health Organization (WHO) recommends a comprehensive set of tobacco cessation interventions, including behavioral support delivered by health-care providers, digital cessation interventions and pharmacological treatments in a first guideline on tobacco cessation.
Research highlights cardiovascular benefits of semaglutide for overweight adults with impaired kidney function
The anti-obesity medication semaglutide may help to prevent heart attacks, strokes, and other major adverse cardiovascular events (MACE) as well as death in adults with
September 13, 2024